Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/febs.16096 http://scihub22266oqcxt.onion/10.1111/febs.16096 34185437!8420456!34185437     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       FEBS+J 2021 ; 288 (17): 5122-5129 Nephropedia Template TP {{tp|p=34185437|t=2021. Targeting neuropilins as a viable SARS-CoV-2 treatment |pdf=|usr=}}{{34185437}} gab.com Text Targeting neuropilins as a viable SARS-CoV-2 treatment JO: FEBS J http://www.kidney.de/pget.php?&tw=1&pmid=34185437 #FOAvip The SARS-CoV-2 pandemic has significantly impacted global health. Research on viral mechanisms, highly effective vaccines, and other therapies is in progress. Neuropilins have recently been identified as host cell receptors enabling viral fusion. Here, we provide context to neuropilin's tissue-specific role in infection and the potential impact of NRP-based therapeutics. We conclude that the central roles of neuropilins in vascular, neural, and other pathways may render it a less suitable target for treating SARS-CoV-2 than agents that target its binding partner, the viral spike protein. Twit Text FOAVip Targeting neuropilins as a viable SARS-CoV-2 treatment ????FEBS J http://www.kidney.de/pget.php?&tw=1&pmid=34185437 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34185437 #FOAvip English Wikipedia <ref>{{Cite pmid|34185437}}</ref> Targeting neuropilins as a viable SARS-CoV-2 treatment #MMPMID34185437 Sarabipour S; Mac Gabhann F FEBS J 2021[Sep]; 288 (17): 5122-5129 PMID34185437show ga The SARS-CoV-2 pandemic has significantly impacted global health. Research on viral mechanisms, highly effective vaccines, and other therapies is in progress. Neuropilins have recently been identified as host cell receptors enabling viral fusion. Here, we provide context to neuropilin's tissue-specific role in infection and the potential impact of NRP-based therapeutics. We conclude that the central roles of neuropilins in vascular, neural, and other pathways may render it a less suitable target for treating SARS-CoV-2 than agents that target its binding partner, the viral spike protein. |Antibodies, Neutralizing/immunology/*therapeutic use[MESH] |Antibodies, Viral/immunology/*therapeutic use[MESH] |COVID-19/blood/*therapy/virology[MESH] |Humans[MESH] |Neuropilins/*genetics/immunology[MESH] |Pandemics[MESH] |SARS-CoV-2/pathogenicity[MESH]Targeting neuropilins as a viable SARS-CoV-2 treatment (epmc).pdf DeepDyve Pubget Overpricing